EUVIMEDEUVIMED entdecken
Crossref

A Novel pH‐Responsive Baicalein@Chitosan Hydrogel for the Topical Treatment of Herpes Simplex Virus Type 1 Skin Infections: Therapeutic Potential and Mechanisms

Yuhui Lu, Liying Zhou, Alu Ouyang, Xin Wang, Xiaoyang Wei, Shangping Xing, Feifei Nong, Jinquan Lin, Haotong Wang, Yuan Li, Jie Deng, Yilu Bao und 3 weitere

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202403961 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yuhui Lu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Guangxi Key Laboratory of Component-Efficacy Relationship of Traditional Chine…. Hauptthemen laut MEDLINE: Flavanones, Chitosan, Herpesvirus 1, Human, Hydrogels. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi, National Natural Science Foundation of China, Guangdong General University Key Project of Basic Research and Applied Basic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herpes simplex virus type 1 (HSV‐1) is a prevalent human pathogen primarily transmitted through skin‐to‐skin contact. Traditional antiviral drugs like acyclovir (ACV) have limitations due to viral resistance and side effects, necessitating the development of alternative therapeutic strategies. Drug‐loaded hydrogels have emerged as a promising approach for managing various skin infections. Considering the low‐pH microenvironment following HSV‐1 infection, a pH‐responsive baicalein@chitosan (B@C) hydrogel is developed for the topical treatment of HSV‐1 skin infections. This hydrogel is synthesized by incorporating baicalein, a natural flavonoid, into a chitosan matrix modified with 4‐formylphenylboronic acid and protocatechualdehyde to achieve potent anti‐HSV‐1 activity and pH‐responsiveness. In vitro results demonstrated the hydrogel's pH‐dependent inhibitory effect on HSV‐1 infections, including ACV‐resistant strains. Subsequent investigations confirmed its efficacy in multiple murine infection models. Mechanistically, the B@C hydrogel inhibited viral replication by modulating the phosphorylation of inhibitor of nuclear factor kappa‐B kinase subunit beta, promoted collagen synthesis, and decreased reactive oxygen species generation. Ultra‐high‐performance liquid chromatography‐tandem mass spectrometry analysis revealed a sustained release of baicalein from the hydrogel, ensuring long‐term drug retention in HSV‐1‐infected skin tissues. Collectively, these findings suggest that the B@C hydrogel holds significant potential for the therapeutic management of HSV‐1 skin infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesChitosanHerpesvirus 1, HumanHydrogelsHerpes SimplexAntiviral AgentsAnimalsMiceHydrogen-Ion ConcentrationHumansFemaleVero CellsAdministration, TopicalVirus ReplicationMice, Inbred BALB CChlorocebus aethiopsSkin

Stichwörter der Autor:innen

HSV‐1 cutaneous infectionsIKK‐β phosphorylationNF‐κB activationbaicaleinchitosan‐based hydrogels

Substanzen

FlavanonesbaicaleinChitosanHydrogelsAntiviral Agents

Autor:innen und Institutionen

  • Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Guangxi Key Laboratory of Component-Efficacy Relationship of Traditional Chinese Medicine, College of Pharmacy, Guangxi Medical University, Nanning,…
  • Department of Scientific Research, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi University of Chinese Medicine, Nanning, 530024, P. R. China.
  • Shunde Vocational and Technical College, Foshan, 528300, P. R. China.

ORCID-Profile: Zhuo Luo

Förderung

  • Natural Science Foundation of Guangxi
  • National Natural Science Foundation of China
  • Guangdong General University Key Project of Basic Research and Applied Basic Research
  • PhD start-up fund of Guangxi University of Chinese Medicine

Zitieren

APA

Lu, Y., Zhou, L., Ouyang, A., Wang, X., Wei, X., Xing, S., Nong, F., Lin, J., Wang, H., Li, Y., Deng, J., Bao, Y., Yang, J., Jin, R., & Luo, Z. (2025). A Novel pH‐Responsive Baicalein@Chitosan Hydrogel for the Topical Treatment of Herpes Simplex Virus Type 1 Skin Infections: Therapeutic Potential and Mechanisms. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403961

Vancouver

Lu Y, Zhou L, Ouyang A, Wang X, Wei X, Xing S, et al. A Novel pH‐Responsive Baicalein@Chitosan Hydrogel for the Topical Treatment of Herpes Simplex Virus Type 1 Skin Infections: Therapeutic Potential and Mechanisms. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403961

BibTeX
@article{Lu2025,
  author = {Lu, Yuhui and Zhou, Liying and Ouyang, Alu and Wang, Xin and Wei, Xiaoyang and Xing, Shangping and Nong, Feifei and Lin, Jinquan and Wang, Haotong and Li, Yuan and Deng, Jie and Bao, Yilu and Yang, Jie and Jin, Ronghua and Luo, Zhuo},
  title = {A Novel pH‐Responsive Baicalein@Chitosan Hydrogel for the Topical Treatment of Herpes Simplex Virus Type 1 Skin Infections: Therapeutic Potential and Mechanisms},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202403961}
}
Kostenlos starten →